Fulcrum Therapeutics (FULC) Treasury Shares (2019 - 2025)
Historic Treasury Shares for Fulcrum Therapeutics (FULC) over the last 7 years, with Q3 2025 value amounting to $69.5 million.
- Fulcrum Therapeutics' Treasury Shares rose 9757775.31% to $69.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.5 million, marking a year-over-year increase of 9757775.31%. This contributed to the annual value of $43072.0 for FY2024, which is 4258.37% down from last year.
- Per Fulcrum Therapeutics' latest filing, its Treasury Shares stood at $69.5 million for Q3 2025, which was up 9757775.31% from $70.7 million recorded in Q2 2025.
- In the past 5 years, Fulcrum Therapeutics' Treasury Shares ranged from a high of $70.7 million in Q2 2025 and a low of $536.0 during Q3 2021
- Its 5-year average for Treasury Shares is $10.1 million, with a median of $77430.0 in 2022.
- In the last 5 years, Fulcrum Therapeutics' Treasury Shares tumbled by 8829.95% in 2021 and then soared by 9757775.31% in 2025.
- Fulcrum Therapeutics' Treasury Shares (Quarter) stood at $536.0 in 2021, then skyrocketed by 14213.06% to $76718.0 in 2022, then dropped by 2.22% to $75017.0 in 2023, then plummeted by 42.58% to $43072.0 in 2024, then skyrocketed by 161225.22% to $69.5 million in 2025.
- Its last three reported values are $69.5 million in Q3 2025, $70.7 million for Q2 2025, and $88048.0 during Q1 2025.